Biologic switching patterns among children with non-systemic juvenile idiopathic arthritis

BACKGROUND: In juvenile idiopathic arthritis (JIA) clinical remission is unattainable in some patients despite modern biologic disease-modifying antirheumatic drugs (bDMARD) therapy and switching bDMARD is required. The best choice of second-line bDMARD remains unclear. This retrospective observatio...

Descripción completa

Detalles Bibliográficos
Autores principales: Pedersen, Mia Lindegaard, Neve-Græsbøll, Amalie, Herlin, Troels, Glerup, Mia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10518086/
https://www.ncbi.nlm.nih.gov/pubmed/37742033
http://dx.doi.org/10.1186/s12969-023-00897-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10518086/
https://www.ncbi.nlm.nih.gov/pubmed/37742033
http://dx.doi.org/10.1186/s12969-023-00897-6

Ejemplares similares